SIOLTA THERAPEUTICS
Siolta Therapeutics is a developer of human microbiome therapeutics intended to prevent and treat inflammatory diseases. The company leverages its deep knowledge of the developing gut microbiome and its role in promoting immune tolerance to develop targeted microbial therapeutics and companion diagnostics for the prevention and treatment of inflammatory diseases, enabling medical researchers to harness information from human microbiome studies to design next-generation microbial therapeutics to prevent inflammatory processes.
SIOLTA THERAPEUTICS
Industry:
Biotechnology Therapeutics
Founded:
2016-01-01
Address:
San Carlos, California, United States
Country:
United States
Website Url:
http://www.sioltatherapeutics.com
Total Employee:
1+
Status:
Active
Contact:
415.991.0947
Email Addresses:
[email protected]
Total Funding:
30 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics Apple Mobile Web Clips Icon Google Tag Manager WordPress Content Delivery Network
Current Advisors List
Current Employees Featured
Founder
Investors List
National Institute of Allergy and Infectious Diseases
National Institute of Allergy and Infectious Diseases investment in Grant - Siolta Therapeutics
Seventure Partners
Seventure Partners investment in Series B - Siolta Therapeutics
Khosla Ventures
Khosla Ventures investment in Series B - Siolta Therapeutics
Global Brain Corporation
Global Brain Corporation investment in Series B - Siolta Therapeutics
Marc Benioff
Marc Benioff investment in Series B - Siolta Therapeutics
SymBiosis LLC
SymBiosis LLC investment in Series B - Siolta Therapeutics
Seventure Partners
Seventure Partners investment in Seed Round - Siolta Therapeutics
Khosla Ventures
Khosla Ventures investment in Venture Round - Siolta Therapeutics
Official Site Inspections
http://www.sioltatherapeutics.com Semrush global rank: 8.76 M Semrush visits lastest month: 261
- Host name: 84.56.180.107.host.secureserver.net
- IP address: 107.180.56.84
- Location: Scottsdale United States
- Latitude: 33.6013
- Longitude: -111.8867
- Metro Code: 753
- Timezone: America/Phoenix
- Postal: 85260
More informations about "Siolta Therapeutics"
About - Siolta Therapeutics
Our patient-centric Precision Symbiotics Platform ™ leverages a proprietary human microbiota biobank, in vitro and in vivo therapeutic phenotype screening, and anaerobic manufacturing …See details»
Siolta Therapeutics - Crunchbase Company Profile
Siolta Therapeutics is a biotech company focused on developing therapeutic microbial consortia to prevent and treat inflammatory diseases.See details»
Siolta Therapeutics, Inc. Company Profile | San Carlos, CA ...
Find company research, competitor information, contact details & financial data for Siolta Therapeutics, Inc. of San Carlos, CA. Get the latest business insights from Dun & Bradstreet.See details»
Siolta Therapeutics - LinkedIn
Siolta Therapeutics is a clinical-stage biotech company developing live biotherapeutics to improve outcomes in conditions with unmet medical needs. Our offices and laboratory are located in San ...See details»
Siolta Therapeutics 2025 Company Profile: Valuation, …
Information on valuation, funding, cap tables, investors, and executives for Siolta Therapeutics. Use the PitchBook Platform to explore the full profile.See details»
Siolta Therapeutics Company Profile | Management and
Find contact information for Siolta Therapeutics. Learn about their Business Services, Research & Development market share, competitors, and Siolta Therapeutics's email format.See details»
Siolta Therapeutics - 2025 Company Profile - Tracxn
Mar 22, 2025 Siolta Therapeutics - Provider of microbiome therapeutics for treating multiple diseases. Raised a total funding of $42M over 2 rounds from 8 investors.See details»
Siolta Therapeutics - VentureRadar
"Siolta Therapeutics is a clinical-stage biotech company on a mission to alleviate the suffering of millions impacted by chronic inflammatory diseases through novel microbiome-based …See details»
Siolta Therapeutics - Craft
Siolta Therapeutics is a biotech company focused on developing therapeutic microbial consortia to prevent and treat inflammatory disease. The company focuses on the clinical development …See details»
Siolta Therapeutics, Inc. | MedPath
Allergic Disease Onset Prevention Study Phase 1 Active, not recruiting Conditions Atopic Dermatitis Type 1 Hypersensitivity Interventions Biological: STMC-103H Biological: Placebo …See details»
Siolta Therapeutics Company Information - Funding, Investors, …
Siolta Therapeutics develops microbiome analyses to test microbial-based therapeutics for the treatment and prevention of inflammatory diseases. The company was founded in 2016 by …See details»
Siolta Therapeutics - Devex
Learn more about Siolta Therapeutics's jobs, projects, latest news, contact information and geographical presence. Pioneering medicine with the power to prevent Siolta Therapeutics is a …See details»
Our Platform - Siolta Therapeutics
A platform focused on translating microbiome science into novel therapeutics for a healthier world Siolta’s patient-centric platform leverages our internal expertise in microbiome science, …See details»
Siolta Therapeutics Raises $12 Million in Series C Financing for ...
Mar 12, 2024 SAN CARLOS, Calif.-- ( BUSINESS WIRE )-- Siolta Therapeutics, a clinical-stage biotech company, has announced the completion of a $12 million Series C financing round. …See details»
Siolta Therapeutics - MBC BioLabs
Sep 24, 2024 Leverages deep knowledge of the human microbiome to develop live biotherapeutic products (LBPs) and diagnostics for the prevention and treatment of a wide …See details»
Siolta Therapeutics Raises $30M Series B for the Prevention and ...
Sep 22, 2020 SAN CARLOS, Calif.--(BUSINESS WIRE)--Sep 22, 2020-- Siolta Therapeutics, a clinical-stage biotech company, announced today it has raised $30M in a series B investment …See details»
Siolta Therapeutics Raises $12 Million in Series C Financing for ...
Mar 13, 2024 Siolta Therapeutics, a clinical-stage biotech company, has announced the completion of a $12 million Series C financing round. The round, co-led by SymBiosis and …See details»
Global Brain has invested in Siolta Therapeutics, Inc., a clinical ...
Global Brain (Global Brain) has invested in Siolta Therapeutics Inc. (Siolta Therapeutics, Founder & CEO: Nikole E. Kimes, PhD), a clinical stage biotech company focused on developing …See details»
Siolta Therapeutics | Insights
Recent biopharmaceutical venture capital financings reflect a worldly investment view, even at the $100m-plus mega-round level where the largest investments tend to be more frequent in the …See details»
Theratechnologies Receives FDA Approval for EGRIFTA WR™ …
New, improved formulation set to replace EGRIFTA SV ® MONTREAL, March 25, 2025 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (“Theratechnologies” or the “Company”) (TSX: TH) …See details»